Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein

Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein

The urgent need for vaccines against Ebola virus (EBOV) was underscored by the large outbreak in West Africa (2014–2016). Since then, several promising vaccine candidates have been tested in pre-clinical and clinical studies. As a result, two vaccines were approved for human use in 2019/2020, of...

Cur síos iomlán

Sábháilte in:
Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Kupke, Alexandra, Dietzel, Erik, Schmidt, Jörg, Shams-Eldin, Hosam, Sauerhering, Lucie, Krähling, Verena, Gellhorn Serra, Michelle, Eickmann, Markus, Becker, Stephan
Formáid: Alt
Teanga:Béarla
Foilsithe / Cruthaithe: Philipps-Universität Marburg 2023
Ábhair:
correlates of protection; nucleoprotein
vaccine
Modified Vaccinia virus Ankara
Ebola virus
glycoprotein
Medizin
Medical sciences Medicine
Rochtain ar líne:An téacs iomlán mar PDF
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
No references were found for this record.

Míreanna comhchosúla